Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Nichi-Iko Pharmaceutical Co Ltd is a major drug manufacturing company in Japan. Its core business includes the manufacture and sale of generic pharmaceutical products, through sales to pharmaceutical wholesalers and medical institutions. The vast majority of the company's sales are derived from prescription drugs. The company operates various subsidiaries across an array of other countries, including Thailand.
Toyama, 930-8583, Japan